Hormone Replacement Therapy (HRT)

Global Market Trajectory & Analytics

MCP-6453

EXECUTIVE ENGAGEMENTS

* Login for a full stack data experience

DATE

APR 2021

TABLES

32

109

EDITION

17

PRICE

USD 5600

CODE

MCP-6453

*Engagement stats are ongoing and dynamic

COMPETITIVE METRICS

	COMPANY	D S N T % *
	Abbott Laboratories, Inc.
	AbbVie, Inc.
	Acerus Pharmaceuticals Corporation
	Acrux Ltd.
	Allergan PLC
	Amgen Ltd.
	Amgen, Inc.
	Amneal Pharmaceuticals, Inc.
	ANI Pharmaceuticals, Inc.
	APS Pharmacy

SUBMIT

Note: Best viewed in Landscape Mode

RESEARCH MODULES MARKET TRENDS EXECUTIVES

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$7.6 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.

The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

SELECT PLAYERS

Abbott Laboratories; Allergan Plc; Bayer AG; Novartis AG; Noven Pharmaceuticals Inc.; Novo Nordisk A/S; Pfizer Inc.; TherapeuticsMD Inc.

SEGMENTS

» Segment (Hormone Replacement Therapy (HRT))

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

Impact of Covid-19 and a Looming Global Recession

An Introduction to Menopause and Hormone Replacement Therapy

Recent Market Activity

The HRT Controversy - An Insight

Newer Studies Challenge WHI Findings and Re-establish Safety of HRT

Revised Recommendations of the NAMS and Endocrine Society

IMS Consensus Guidelines Paving Way for More Clarity of HRT

The Regional Divide

Increasing Number of Menopausal Women - A Major Market Driver

New Bioidentical Drugs Serve Unmet Market Needs

Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions

Intense Competition Marks the Global HRT Market

The Premarin Saga

Estrace Cream Drives Revenue Gains in Allergan’s HRT Portfolio

2. FOCUS ON SELECT PLAYERS

Abbott Laboratories (USA)

Allergan Plc (Ireland)

Bayer AG (Germany)

Noven Pharmaceuticals, Inc. (USA)

Novartis AG(Switzerland)

Novo Nordisk A/S (Denmark)

Orion Pharma AB (Finland)

Pfizer, Inc. (USA)

TherapeuticsMD, Inc. (USA)

3. MARKET TRENDS & DRIVERS

Unmet Needs in Combination Therapies for HRT drive Research for New Medicines

Topical Estrogens - More Safe and Effective

Transdermal HRT Products Present Exciting Opportunities

Phytoestrogens - The New Panacea for Menopausal Symptoms?

Diet Link to Menopause Symptoms Raises Interest

Impact of Soy and Other Phytoestrogens - A Reality Check

EstroG - A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms

The Growing Buzz around Bioidentical Drugs

Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?

Pellet Therapy - A New Innovation Downsizes Conventional Issues with Bioidentical HRT

Direct-to-Consumer Advertising for HRT - A Mixed Bag

Estriol: The Next Generation Estrogen Therapy?

What Makes Estriol Work?

Topical Estriol - More Promising in Safety

Estriol - Used More Commonly Outside the US

Entry of Generics Threatens Market Growth Prospects

Are Non-Hormonal Therapies A Threat to HRT?

Earlier Failures Induce Lethargy in Non-Hormonal Therapies

4. GLOBAL MARKET PERSPECTIVE

World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

World 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES

USA Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

USA Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

CANADA

Canada Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Canada Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

JAPAN

Japan Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Japan Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

CHINA

China Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

China Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

EUROPE

Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Europe Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Europe 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027

FRANCE

France Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

France Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

GERMANY

Germany Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Germany Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

ITALY

Italy Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Italy Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

UNITED KINGDOM

UK Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

UK Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

REST OF EUROPE

Rest of Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

ASIA-PACIFIC

Asia-Pacific Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

REST OF WORLD

Rest of World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

IV. COMPETITION

Total Companies Profiled: 47

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.